NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BlueCare Discovery

BlueCare Discovery

Private
NantesHealthcare & Life Scienceshttps://bc-discovery.com

Last Round

VC Round

Mar 1, 2025

Company Overview

BlueCare Discovery is a biotechnology company that develops bioactive compounds from microalgae to prevent and treat neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share, Services & Consulting

AI Layer

Application

Keywords

neurodegenerative diseasedrug discoveryAI drug discoverymarine microalgaebioactive compound discoverybiotechdrug discovery platformneuroprotective therapypreclinical drug developmentAlzheimer's therapyfirst-in-class therapeuticsdeep techbiomimicrynutraceuticalsdermocosmeticsanimal health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BlueCare Discovery Comparables

Compare BlueCare Discovery with similar companies based on industry and business-model similarity.

BlueCare Discovery comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Perha Pharmaceuticals
83%
Nevrargenics Ltd
78%
Sea4Us
73%

BlueCare Discovery Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 1, 2025
SeedSep 15, 2022

Key People

Founding team and executive leadership

Benoît Serive

Founder, CEO

Founding Team

Hervé Jullien

Advisor to the CEO

Executive Team

BlueCare Discovery Investors

Notable investors and investment history

BlueCare Discovery investors
InvestorRounds
Imagination MachineSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2025

    $1.08M raised in a VC Round.

  • Nov 11, 2024

    Monthly visitors increased 127% MoM.

BlueCare Discovery Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BlueCare Discovery Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BlueCare Discovery's valuation, stock price, and market status.

Firmographic Details

HeadquartersNantes
Employee Range3
Year Founded2022
Last FundingMar 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.